Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes,Diabetes Technology & Therapeutics

当前位置： X-MOL 学术 › Diabetes Technol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes
Diabetes Technology & Therapeutics ( IF 5.7 ) Pub Date : 2021-09-01 , DOI: 10.1089/dia.2021.0037
Pilar Isabel Beato-Víbora ₁ , Fabiola Gallego-Gamero ₁ , Ana Ambrojo-López ₁ , Estela Gil-Poch ₂ , Irene Martín-Romo ₁ , Francisco Javier Arroyo-Díez ₂

Affiliation

Background: Advanced hybrid closed-loop (AHCL) systems represent the next step of automation intended to maximize normoglycemia in people with type 1 diabetes (T1D). In the AHCL MiniMed 780G system, different algorithm glucose targets for insulin infusion are available and autocorrection boluses are delivered. The aim was to prospectively evaluate the impact of the implementation of this AHCL system in a clinical setting.

中文翻译：

在患有 1 型糖尿病的青少年和成人中实施先进的混合闭环系统后，时间范围内的快速改善

背景：先进的混合闭环 (AHCL) 系统代表了自动化的下一步，旨在最大限度地提高 1 型糖尿病 (T1D) 患者的血糖正常值。在 AHCL MiniMed 780G 系统中，提供用于胰岛素输注的不同算法葡萄糖目标，并提供自动校正推注。目的是前瞻性地评估该 AHCL 系统在临床环境中实施的影响。

更新日期：2021-09-03

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11